Overview
Breast cancer is a malignant tumor that develops from the cells of the breast, most often in the ducts or lobules of the glandular tissue, and is the most commonly diagnosed cancer in women worldwide, though it can also occur in men. The disease is biologically heterogeneous, comprising subtypes defined by features such as hormone-receptor status and HER2 expression, which influence prognosis and guide therapy; triple-negative breast cancer, lacking these receptors, is associated with more limited targeted options. Risk is shaped by genetic, hormonal, reproductive, and lifestyle factors, and outcomes depend strongly on stage at diagnosis, making early detection and screening central to survival. Management is multimodal and may combine surgery, radiotherapy, chemotherapy, hormonal (endocrine) therapy, and targeted agents, selected according to tumor biology and extent of disease, including metastatic spread. Survival and survivorship encompass not only tumor control and the biology of progression and metastasis but also the psychological and supportive-care needs of patients. Research published in this area reflects these themes, including studies of survival in cancer-center cohorts, prognostic and histopathological grading, triple-negative disease and lymph-node metastasis, chemokine signaling and metastatic pathways, candidate anticancer compounds, treatment after brain metastasis, and the mental-health and psycho-oncological dimensions of living with breast cancer.
Research published in this journal
12 peer-reviewed articles, ranked by relevance. Each links to its DOI.
Metabolic Correction Therapy as Adjuvant Treatment for Breast Cancer Patients: A Case Report
Investigation and Analysis on Mental Health State of Breast Cancer Patients in China
The Effectiveness of Cognitive-Analytic Therapy in Women Diagnosed with Breast Cancer and Post-Traumatic Stress Disorder
Risk Factors Associated with Breast Cancer
Assessment of Anticancer Effect of Alendronate in Breast Cancer: An In vitro Study
Comparison of Phosphohistone H3 Immunohistochemical Staining, Ki-67, and H&E Mitotic Count in Invasive Breast Carcinoma
Deficits in Psycho-Oncological Care among Turkish Immigrant Women with Breast Cancer in Germany – An Interview Study.
Chemotherapy after whole-brain radiotherapy: a prognostic factor for metastatic breast cancer
Selective Cytotoxicity of Damsin Derivatives in Breast Cancer Cells
Analysis of Clinical Prognostic Variables for Triple Negative Breast Cancer Histological Grading and Lymph Node Metastasis
Breast Cancer, Chemokines, And Metastasis: A Search for Decoy Ligands of the CXCR4 Receptor
How this research is being cited
The 12 articles above have been cited 55 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2025 · European Journal of Pharmacology
-
Aixin Wang et al. · 2025 · European Journal of Pharmacology
-
2024 · Veterinary World
-
2024 · Veterinary World
-
2024 · European journal of medical research
-
2024 ·
-
2024 · Cancers
-
G. Mizejewski · 2024 · Cancers
A sample of recent works citing this journal's research on Breast Cancer, linking to each citing work.